Jeremiah Sundararaj Stanleyraj, Miyakawa Kei, Matsunaga Satoko, Nishi Mayuko, Kudoh Ayumi, Takaoka Akinori, Sawasaki Tatsuya, Ryo Akihide
Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan.
Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Front Microbiol. 2021 Apr 27;12:643407. doi: 10.3389/fmicb.2021.643407. eCollection 2021.
Type-I interferons (IFN-I) are the innate immune system's principal defense against viral infections. Human immunodeficiency virus-1 (HIV-1) has evolved several ways to suppress or evade the host's innate immunity in order to survive and replicate to sustain infection. Suppression of IFN-I is one among the multiple escape strategies used by HIV-1 to prevent its clearance. HIV-1 protease which helps in viral maturation has also been observed to cleave host cellular protein kinases. In this study we performed a comprehensive screening of a human kinase library using AlphaScreen assay and identified that TANK binding kinase-1 (TBK1) was cleaved by HIV-1 protease (PR). We demonstrate that PR cleaved TBK1 fails to phosphorylate IFN regulatory factor 3 (IRF3), thereby reducing the IFN-I promoter activity and further reveal that the PR mediated suppression of IFN-I could be counteracted by protease inhibitors (PI) . We have also revealed that mutations of HIV-1 PR that confer drug resistance to PIs reduce the enzyme's ability to cleave TBK1. The findings of this study unearth a direct link between HIV-1 PR activity and evasion of innate immunity by the virus, the possible physiological relevance of which warrants to be determined.
I型干扰素(IFN-I)是先天免疫系统抵御病毒感染的主要防线。人类免疫缺陷病毒1型(HIV-1)已经进化出多种方式来抑制或逃避宿主的先天免疫,以便存活和复制以维持感染。抑制IFN-I是HIV-1用于防止其被清除的多种逃逸策略之一。人们还观察到,有助于病毒成熟的HIV-1蛋白酶可切割宿主细胞蛋白激酶。在本研究中,我们使用AlphaScreen检测法对人类激酶文库进行了全面筛选,确定TANK结合激酶1(TBK1)可被HIV-1蛋白酶(PR)切割。我们证明,被PR切割的TBK1无法磷酸化干扰素调节因子3(IRF3),从而降低IFN-I启动子活性,并进一步揭示PR介导的IFN-I抑制作用可被蛋白酶抑制剂(PI)抵消。我们还发现,对PI产生耐药性的HIV-1 PR突变会降低该酶切割TBK1的能力。本研究结果揭示了HIV-1 PR活性与病毒逃避先天免疫之间的直接联系,其可能的生理相关性有待确定。